The sWAT UCP2 is positively correlated with both circulating and depot-specific adiponectin levels, and lowered adiponectin is associated with insulin resistance and dyslipidemia in obese subjects [76]. The gene discussed is ADIPOQ; the disease is metabolic syndrome.